Sort
50,496 grants matching “lung cancer”
Clinical Pharmacogenetics
$678,469William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Therapeutic Targeting of Casein Kinase-1-delta in Primary and Metastatic Breast Cancer
$678,459Derek Ronald Duckett · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2018 · CA
Streamlined and comprehensive circulating tumor exosome profiling by microfluidic arrayed nanoplasmonic sensors and actuators
$678,432Wei-Chuan Shih · University Of Houston · R01 · FY2021 · EB
Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics
$678,352Phil Crews · University Of California Santa Cruz · R01 · FY2013 · CA
Rhesus HHV-8 homologue in AIDS-related malignancies
$678,245Scott W Wong · Oregon Health & Science University · R01 · FY2019 · CA
Simulating Protein Structures, Complexes, And Dynamics
$678,089Peter J Steinbach · Center For Information Technology · ZIA · FY2016 · CT
Multi-level interventions for addressing tobacco cessation and SDOH in Community Health Centers (CHCs)
$678,036Chelsey Schlechter · Utah State Higher Education System--University Of Utah · U54 · FY2025 · CA
FFPE Validation of a Survival Gene Signature in HPV-Negative Oral Cavity Cancer
$678,016Chu Chen · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA
Megakaryocyte regulation by the gut microbiome
$678,002Melody Y Zeng · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · HL
TARGETED INHIBITION OF MUTANT KRAS ONCOGENE SIGNALING BY RAS MIMETICS AS A THERAPEUTIC APPROACH FOR LUNG CANCER
$678,000Icahn School Of Medicine At Mount Sinai · · FY2017 · Department of the Army
Personalizing Post-Polypectomy Surveillance for Colorectal Cancer Prevention
$677,942Jeffrey Kuang Zou Lee · Kaiser Foundation Research Institute · R37 · FY2025 · CA
Tumor gene expression in vitro and in vivo
$677,938Douglas R. Lowy · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
The Impact of Tobacco Exposure on the Lungs Innate Defense System
$677,854Robert Tarran · Univ Of North Carolina Chapel Hill · P50 · FY2015 · HL
Modulation of Therapeutic Response
$677,808James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA
Intensive tailored exercise training with NAD+ precursor supplementation to improve muscle mass and fitness in adolescent and young adult survivors of hematopoietic stem cell transplantation
$677,805Sogol Mostoufi-Moab · Children'S Hosp Of Philadelphia · R01 · FY2022 · CA
Nanotechnology Platform for Targeting Solid Tumors
$677,789Jan E Schnitzer · Sidney Kimmel Cancer Center · R01 · FY2006 · CA
Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer
$677,787Christian Maximillian Schmidt · Indiana University Indianapolis · U01 · FY2021 · CA
Development Of Drugs Acting At Adenosine Receptors
$677,639Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK
Targeting novel therapeutic vulnerabilities in LKB1 mutant tumors.
$677,471Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2020 · CA
Targeting novel therapeutic vulnerabilities in LKB1 mutant tumors.
$677,442Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2021 · CA
Use of advanced imaging techniques to improve diagnostic methods for ARDS
$677,379Robert Scott Harris · Massachusetts General Hospital · R01 · FY2017 · HL
Use of advanced imaging techniques to improve diagnostic methods for ARDS
$677,379Robert Scott Harris · Massachusetts General Hospital · R01 · FY2016 · HL
Genetic and Epigenetic Biomarkers for SCC of the Lung
$677,372Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · R01 · FY2012 · ES
Genetic and Epigenetic Biomarkers for SCC of the Lung
$677,372Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · R01 · FY2011 · ES
Medicaid data as a complement to cohort studies for investigating cancers among older people with HIV
$677,064Corinne E. Joshu · Johns Hopkins University · R01 · FY2021 · CA